Haleon PLC (NYSE: HLN) witnessed a pre-market surge of 5.11% on Friday, driven by the company's positive earnings report and optimistic outlook for the year ahead. The stock's rally reflects investor confidence in Haleon's growth strategies, particularly in emerging markets and its robust oral health division.
In its Q4 2024 earnings call, Haleon highlighted strong momentum in key emerging markets such as India and China, which contributed significantly to the company's overall growth. Additionally, the oral health division has been performing exceptionally well, with plans for further expansion in distribution and geographical rollout, supported by a strong innovation pipeline.
Haleon expressed confidence in achieving 4% to 6% growth for the full year, underpinned by its market expansion strategies and continued focus on innovation. The company has also increased its advertising and promotional (A&P) investment by 10.2% to support growth initiatives, including enhanced expert coverage and sampling efforts.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.